Cefetrizole

Cefetrizole

SCHEMBL31469874

O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3ncn[nH]3)CS[C@H]12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 9/20 0.62
MAPT P10636 5/20 0.62
HPGD P15428 3/20 0.62
SLC22A6 Q4U2R8 3/20 0.62
SLC22A8 Q8TCC7 3/20 0.62
SLC22A11 Q9NSA0 3/20 0.62
NR1I2 O75469 2/20 0.62
CTDSP1 Q9GZU7 2/20 0.62
DNMT1 P26358 1/20 0.62
LMNA P02545 5/20 0.55
KDM4E B2RXH2 3/20 0.55
MEN1 O00255 3/20 0.55
KMT2A Q03164 3/20 0.55
ALDH1A1 P00352 1/20 0.55
ALOX15 P16050 1/20 0.55
RECQL P46063 1/20 0.55
PTGS1 P23219 1/20 0.55
HSD17B10 Q99714 4/20 0.52
CYP3A4 P08684 2/20 0.52
POLB P06746 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefetrizole SCHEMBL27920203 0.99 TDP1 (0.61) TDP1MAPTHPGDSLC22A6SLC22A8
SCHEMBL11518451 0.87 TDP1 (0.62) TDP1MAPTHPGDSLC22A6SLC22A8
SCHEMBL11518445 0.87 TDP1 (0.62) TDP1MAPTHPGDSLC22A6SLC22A8
SCHEMBL11522515 0.86 TDP1 (0.66) TDP1MAPTHPGDSLC22A6SLC22A8
SCHEMBL11522530 0.86 TDP1 (0.66) TDP1MAPTHPGDSLC22A6SLC22A8
SCHEMBL11587845 0.86 TDP1 (0.62) TDP1MAPTHPGDSLC22A6SLC22A8
Cefetrizole SCHEMBL11523034 0.86 TDP1 (0.62) TDP1MAPTHPGDSLC22A6SLC22A8
Cefetrizole SCHEMBL11523038 0.86 TDP1 (0.62) TDP1MAPTHPGDSLC22A6SLC22A8
SCHEMBL11587846 0.86 TDP1 (0.62) TDP1MAPTHPGDSLC22A6SLC22A8
Cefetrizole SCHEMBL614464 0.86 TDP1 (0.62) TDP1MAPTHPGDSLC22A6SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119709984-A Use of NLRC3 in the preparation of a product for diagnosing, screening or assessing coronary atherosclerotic heart disease 梅州市人民医院(梅州市医学科学院) 2025-03-28 CN disclosed